| Literature DB >> 23875175 |
Lakshmipathi Vadlakonda1, Abhinandita Dash, Mukesh Pasupuleti, Kotha Anil Kumar, Pallu Reddanna.
Abstract
Entities:
Year: 2013 PMID: 23875175 PMCID: PMC3710993 DOI: 10.3389/fonc.2013.00186
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Schematic representation of energy status of cells modulating cell signaling and mitochondrial function. Under high energy (ATP/AMP ratio)/nutrient levels the insulin/insulin growth factor signaling (IIS) activates PI3K-Akt pathway. Initiation of PI3K-Akt signaling takes place when mTORC2 is active and phosphorylates Akt on Serine473. FoxO is the transcription factor of rictor, a critical component of mTORC2. Akt is further phosphorylated at Threonine 308 by IIS mediated PIPDK (originally PDK1). High ATP/AMP ratio stabilizes the phosphorylations and activated Akt phosphorylates FoxO, which leads to its exclusion from the nucleus. Akt inactivates tuberous sclerosis complex (TSC) 1/2 resulting in activation of mTORC1. mTORC1 promotes biosynthetic activity, inhibits autophagy. When ATP/AMP ratio is high, mitochondria stop synthesizing ATP and generate reactive oxygen species (ROS) and activate metabolite shuttles to replenish the amino acids and citrate, the precursors of protein and membrane lipids. Reduction in the ATP/ADP ratio, on the other hand, results in activation of AMPK, which activates autophagy. FoxO translocates into nucleus transcribes sestrins which inhibit mTORC1 and activates mTORC2 by transcribing rictor. The activation of glycolysis and glucose transport by Akt S473 and AMPK increases the ATP/ADP ratio there by reactivating the cycle. Under normal and healthy dietary conditions a perfect balance between ATP production, ROS generation, and biosynthetic processes is cyclically maintained by activation–inactivation cycles of autophagy modulated by alternate activation and inactivation cycle of AMPK and mTORC1. Under surplus nutrients/inflammatory conditions, a deregulated hyper activated mTORC1 leads to either carcinogenesis or insulin resistance. A growing tumor, with increased population of cells is heterogeneous with mixed population of cells, either deprived of oxygen or having access to it. It maintains a metabolic symbiosis with hypoxic cells surviving on glucose uptake and anaerobic glycolysis, while those having access to oxygen thrive on lactate accumulating in the neighborhood (microenvironment). Akt, protein kinase B (T308, S473 – Phosphorylated sites Threonine 308 and Serine 473); AMPK, AMP activated protein kinase; FoxO, fork head transcription factors of O group; GSK3β, glycogen synthase kinase3β; GLUT, glucose transporter; IGF, insulin growth factor; IRS, insulin receptor substrate; mTORC1, 2, mechanistic target of rapamycin Complex 1 and 2 (mTOR: formerly known as mammalian target of rapamycin); PIP2, phosphatidylinositol 4,5 bisphosphate; PIP3, phosphatidylinositol 3,4,5 trisphosphate; PIPDK, phosphoinositide dependent kinase 1 (the abbreviation PIPDK is preferred over the original PDK1 in the article to avoid confusion with the pyruvate dehydrogenase kinase, which is also abbreviated as PDK1 in the literature); PI3K, Phosphatidylinositol 3-kinases; Rictor, a Component of mTORC2; p70S6K, The p70 Ribosomal S6K; ROS, reaction oxygen species; Sestrins, stress response proteins.